Regencell Bioscience Holdings Limited - stock earnings

RGC Quarterly earnings

DateEarningsRevenue
2023Q3 -2.6 million USD ? USD
2023Q1 -1321 USD ? USD
2022Q4 -3.2 million USD ? USD
2022Q3 -1613 USD -2.3 billion USD
2022Q2 -1.9 million USD ? USD
2022Q1 -1.9 million USD ? USD
2021Q4 -1.8 million USD ? USD
2021Q3 -65.2 million USD -2.3 billion USD
2017Q4 28.9 million USD 861.6 million USD
2017Q3 11.4 million USD 716.0 million USD
2017Q2 23.6 million USD 764.2 million USD
2017Q1 48.4 million USD 821.2 million USD
2016Q4 53.9 million USD 812.6 million USD
2016Q3 42.3 million USD 811.5 million USD
2016Q2 33.5 million USD 785.9 million USD
2016Q1 40.7 million USD 787.1 million USD
2015Q4 55.0 million USD 848.2 million USD
2015Q3 21.9 million USD 725.0 million USD
2015Q2 53.4 million USD 862.8 million USD
2015Q1 23.1 million USD 691.3 million USD
2014Q4 46.3 million USD 799.1 million USD
2014Q3 26.7 million USD 693.8 million USD
2014Q2 33.8 million USD 770.3 million USD
2014Q1 -1.2 million USD 726.9 million USD
2013Q4 24.0 million USD 739.9 million USD
2013Q3 75.1 million USD 813.1 million USD
2013Q2 36.1 million USD 842.3 million USD
2013Q1 22.5 million USD 642.8 million USD
2012Q4 37.3 million USD 723.1 million USD
2012Q3 24.0 million USD 692.9 million USD
2012Q2 37.2 million USD 723.3 million USD
2012Q1 46.3 million USD 684.9 million USD
2011Q4 4.1 million USD 613.9 million USD
2011Q3 25.0 million USD 743.6 million USD
2011Q2 34.8 million USD 753.3 million USD
2011Q1 -23.6 million USD 570.9 million USD
2010Q4 13.7 million USD 661.0 million USD
2010Q3 42.6 million USD 696.4 million USD
2010Q2 12.6 million USD 1.4 billion USD
2010Q1 16.0 million USD 719.0 million USD
2009Q4 35.5 million USD 765.6 million USD
2009Q3 -2.0 million USD 674.0 million USD
2009Q2 40.0 million USD 789.0 million USD
2009Q1 21.0 million USD 665.0 million USD
2008Q4 30.0 million USD 711.0 million USD
2008Q3 32.0 million USD 758.0 million USD
2008Q2 13.0 million USD 676.0 million USD
2008Q1 -3.0 million USD 626.0 million USD
2007Q4 24.0 million USD 600.0 million USD
2007Q3 58.0 million USD 753.0 million USD
2007Q2 52.0 million USD 683.0 million USD
2007Q1 229.0 million USD 625.0 million USD
2006Q4 29.0 million USD 653.0 million USD
2006Q3 30.0 million USD 676.0 million USD
2006Q2 16.0 million USD 684.0 million USD
2006Q1 11.0 million USD 585.0 million USD
2005Q4 35.0 million USD 668.0 million USD
2005Q3 17.0 million USD 628.0 million USD
2005Q2 26.4 million USD 643.1 million USD
2005Q1 13.1 million USD 577.0 million USD
2004Q4 55.0 million USD 1.9 billion USD
2004Q3 27.8 million USD 611.3 million USD
2004Q2 -15.0 million USD 133.0 million USD
2004Q1 22.0 million USD 540.0 million USD
2003Q4 141.0 million USD 1.9 billion USD
2003Q3 44.0 million USD 629.0 million USD
2003Q2 12.0 million USD 120.0 million USD
2003Q1 35.0 million USD 528.0 million USD
2002Q4 81.0 million USD 1.6 billion USD
2002Q3 36.0 million USD 571.0 million USD
2002Q2 38.0 million USD 607.0 million USD

RGC Yearly earnings

DateEarningsRevenue
2023 -5.9 million USD ? USD
2022 -7.4 million USD ? USD
2021 -1.3 million USD ? USD
2020 -812371 USD ? USD
2019 -390990 USD ? USD
2018 112.3 million USD 3.2 billion USD
2017 170.4 million USD 3.2 billion USD
2016 153.4 million USD 3.1 billion USD
2015 105.6 million USD 3.0 billion USD
2014 157.7 million USD 3.0 billion USD
2013 144.8 million USD 2.8 billion USD
2012 40.3 million USD 2.7 billion USD
2011 77.6 million USD 2.8 billion USD
2010 95.5 million USD 2.9 billion USD
2009 72.0 million USD 2.8 billion USD
2008 363.0 million USD 2.7 billion USD
2007 86.0 million USD 2.6 billion USD
2006 91.0 million USD 2.5 billion USD
2005 82.0 million USD 2.5 billion USD
2004 185.0 million USD 2.5 billion USD
2003 117.0 million USD 2.1 billion USD

RGC

Price: 4.50USD

52 week price:
3.45
31.30

Payout Ratio Range:
66.57%
255.30%

Earnings Per Share: -0.45 USD

P/E Ratio: -17.78

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 700

Ebitda: 521.8 million

Market Capitalization: 45.5 million

Average Dividend Frequency: 4

Links: